Analysts think SCPH stock price could increase by 534%
Apr 11, 2025, 11:25 AM
20.90%
What does SCPH do
scPharmaceuticals, based in Burlington, Massachusetts, focuses on developing subcutaneous delivery products like FUROSCIX for outpatient care. The company, founded in 2017 and employing 135 staff, aims to enhance patient care and reduce healthcare costs.
8 analysts think SCPH stock price will increase by 534.33%. The current median analyst target is $12.75 compared to a current stock price of $2.01. The lowest analysts target is $11.11 and the highest analyst target is $26.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
